Abstract
By promoting the inflammatory process in the arterial wall,Chlamydia pneumoniae (CPN) and human cytomegalovirus (CMV) participate in the pathogenesis of cardiovascular disease (CVD). Since patients with diabetes mellitus (DM) are at high risk of CVD, we studied markers of CMV and CPN infection in DM patients as possible predictors of cardiovascular complications. The seroprevalence rates of CMV in 44 DM patients and matched controls were 74 and 88 %, respectively. Compared with controls, patients showed lower titers of IgG against CMV (p < 0.001) and higher titers of genus-specific IgA against CPN (p = 0.006). The titers of genus-specific IgG and prevalence rates of type-specific anti-CPN IgA, IgG or IgM were similar in both DM patients and controls. Serological markers of either active or recent CPN infection were detected in 54 % of patients and 59 % of controls. However, CPN DNA was not detected in the blood of any DM patient. CMV DNA was found in the blood of 1 (2.3 %) patient. The results do not indicate an increased rate of CMV or CPN infection in patients with type II DM.
Similar content being viewed by others
Abbreviations
- CMV:
-
cytomegalovirus
- CPN:
-
Chlamydia pneumoniae
- CVD:
-
cardiovascular diseases
- DM:
-
diabetes mellitus
- MIF:
-
microfluorescence
References
Altannavch T., Roubalová K., Brož J., Hrubá D., Anděl M.: Serological markers ofChlamydia pneumoniae, cytomegalovirus andHelicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris.Centr.Eur.J.Publ.Health 11, 102–106 (2003).
Bas S., Muzzin P., Ninet J., Bornard J.E., Scieux C., Vischer T.L.: Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test and immunoassays using different recombinant proteins as antigens.J.Clin.Microbiol. 39, 1368–1377 (2004).
Bulut Y., Faure E., Thomas L., Karahashi H., Michelsen K.S., Equils O., Morrison S.G., Morrison R.P., Arditi M.: Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in MyD88-dependent pathway.J.Immunol. 168, 1435–1440 (2002).
Dandona P., Ajada A., Bandyopadhyay A.: Inflammation: the link between insulin resistance, obesity and diabetes.Trends Immunol. 25, 4–7 (2004).
Danesh J., Collins R., Peto R.: Chronic infections and coronary heart disease: is there a link?Lancet 350, 430–436 (1997).
Dowell S.F., Peeling R.W., Boman J., Carlone G.M., Fields B.S., Guarner J., Hammerschlag M.R., Jackson L.A., Kuo C.C., Maass M., Messmer T., Talkington D.F., Tondella M.L., Zaki S.R.: StandardizingChlamydia pneumoniae assays: recommendations from the centers for disease control and prevention (USA) and laboratory centre for disease control (Canada).Clin.Infect.Dis. 33, 492–503 (2001).
Greelings S., Hoepelman A.: Immune dysfunction in patients with diabetes mellitus (DM).FEMS Immunol.Med.Microbiol. 26, 259–265 (1999).
High K.P.: Atherosclerosis and infection due toChlamydia pneumoniae or cytomegalovirus: weighing the evidence.Clin.Infect.Dis. 28, 746–749 (1999).
Hoymans V.Y., Bosmans J.M., Van Rentherghem L., Mak R., Ursi D., Wuyts F., Vrints C.J., Ieven M.: Importance of methodology in determination ofChlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis.J.Clin.Microbiol. 41, 4049–4053 (2003).
Rajagopalan S.: Serious infections in elderly patients with diabetes mellitus.Clin.Infect.Dis. 40, 990–996 (2005).
Schäffer P., Braun R.W., Mähring K., Henco K., Kang J., Wendland T., Kühn J.E.: Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested polymerase chain reaction and temperature gradient gel electrophoresis.J.Gen.Virol. 74, 2699–2707 (1993).
Schummacher H.R., Lerkerod A.B., Seljeflot I., Sommervoll L., Holme I., Otterstad J.E., Arnesen H.:Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals.J.Clin.Microbiol. 39, 1859–1864 (2001).
Sodja I.: Serological survey of antibodies against chlamydiae.Zprvy CEM 7 (Suppl. 1), 34–36 (1998).
Thomsen R.W., Hundborg H.H., Lervang H.H., Johnsen S.P., Schonheyder H.C., Sorensen H.T.: Diabetes mellitus as a risk factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults.Clin.Infect.Dis. 40, 628–631 (2005).
Author information
Authors and Affiliations
Corresponding author
Additional information
This project was supported by grant no. 1A8259-3/2004 of theInternal Grant Agency of the Ministry of Health of the Czech Republic.
Rights and permissions
About this article
Cite this article
Roubalová, K., Brož, J., Hrubá, D. et al. Prevalence of active infection withChlamydia pneumoniae and human cytomegalovirus in patients with type II diabetes mellitus. Folia Microbiol 52, 287–290 (2007). https://doi.org/10.1007/BF02931311
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02931311